Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

      November 7, 2025
      Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
      Research & Development

      Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

      July 30, 2025
      Research & Development

      $20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

      July 11, 2025
  • Clinical
    • Clinical

      J&J Reports Phase 3 Results Showing Tecvayli Benefit as Monotherapy in Multiple Myeloma

      January 20, 2026
      Clinical

      BMS’ Camzyos Scores Big Trial Win, Expansion to Adolescent Patients Imminent

      January 19, 2026
      Clinical

      MetaVia Reports Phase 1 Results for DA-1726 Showing 9.1% Average Weight Loss

      January 13, 2026
      Clinical

      Nido closes after phase 2 trial of flagship program unsuccessful

      January 13, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      AstraZeneca Acquires Remaining China Rights to C-CAR031 in $630 Million Agreement

      January 21, 2026
      Commercial

      AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

      January 14, 2026
      Commercial

      Samsung Biologics to Shell Out $280M to Acquire GSK’s U.S. Plant

      January 3, 2026
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      Reg impact assessment next in GenAI’s sights, experts claim

      June 26, 2025
      Insights

      The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

      December 1, 2024
      Insights

      Improving life science R&D outcomes with AI

      November 8, 2024
      Insights

      The medical device sector’s surging regulatory burden: how are suppliers coping?

      October 12, 2024
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Four Drugs

Tag: Four Drugs

Four Drugs
Regulatory

FDA Pushes Back Review Decisions for Four Drugs in National Priority Voucher Program

Editorial Team -
January 20, 2026
0

Editor Picks

Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

September 18, 2024

Morphic’s EMERALD-1 trial for ulcerative colitis disappoints

September 26, 2023

Moderna Reveals Promising Melanoma Data Behind Decision to Proceed With Cancer Candidate

October 15, 2025

Must Read

AstraZeneca Acquires Remaining China Rights to C-CAR031 in $630 Million Agreement

January 21, 2026

FDA Pushes Back Review Decisions for Four Drugs in National Priority Voucher Program

January 20, 2026

J&J Reports Phase 3 Results Showing Tecvayli Benefit as Monotherapy in Multiple Myeloma

January 20, 2026

Hot Topics

  • Clinical383
  • Commercial359
  • Regulatory301
  • Research & Development102
  • Manufacturing77
  • Newsletter59
  • Technology40
  • News31
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial